Abstract
Cardiovascular Disease (CVD) is one of the leading causes of death worldwide and its prevalence is expected to continue to rise in the coming years [1]. The American Heart Association (AHA) estimates that one in three people will experience CVD at some point in their lifetime [2]. Coronary Artery Disease (CAD) and ischemic stroke are the most common clinical manifestations of CVD [3]. Despite the efforts to decrease the disease’s incidence and prevalence through primary and secondary prevention strategies, the risk continues to be substantial. This highlights the need to identify accurate and reliable predictors of future cardiovascular events for risk stratification and personalized preventive strategies. Lipoproteins have gained attention as potential predictive values due to their involvement in atherogenesis and plaque formation.
Citation
Tahir MT, Simhachalam Kutikuppala LV, Hassan T, Duffee DF (2023) Lipoprotein-A vs. B: The Better Predictive Marker of Cardiovascular Disease. SM J Cardiol Cardiovasc 7: 2.